AbbVie
E184183
AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.
All labels observed (2)
How this entity was disambiguated
This entity first appeared as the object of triple T1633920 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: AbbVie Context triple: [Calico LLC, collaboratesWith, AbbVie]
-
A.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
B.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
-
C.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
D.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
E.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: AbbVie Target entity description: AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.
-
A.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
B.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
-
C.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
D.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
E.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
- F. None of above. chosen
Statements (50)
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: AbbVie Description of subject: AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.
Referenced by (11)
Full triples — surface form annotated when it differs from this entity's canonical label.